Skip Ribbon Commands
Skip to main content

Steering Committee

Prof Tin Aung.jpgProf Aung Tin
MBBS (Singapore), FRCS(Ed), FRCOphth (UK), MMed (Ophth) (Singapore), FAM (Singapore), PhD (London)
Executive Director, Singapore Eye Research Institute; 
Deputy Medical Director/Vice Chair (Research), Singapore National Eye Centre
Senior Consultant, Glaucoma Department, Singapore National Eye Centre;
Professor, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore
Kwan Im Thong Hood Cho Temple Professor of Ophthalmology, Duke-NUS Medical School, Singapore


After receiving his MBBS and Master of Medicine in Ophthalmology from the National University of Singapore, Prof Aung obtained the Fellowships of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists in 1997. He completed a glaucoma fellowship in the Singapore National Eye Centre in 1999-2000, and from 2000-2003, he was trained at Moorfields Eye Hospital in London and the Institute of Ophthalmology, University College London. In 2003, Prof Aung was awarded a PhD in Molecular Genetics from University College London, UK.

Professor Aung Tin is a highly accomplished clinician scientist in ophthalmology. He is currently Executive Director of the Singapore Eye Research Institute (SERI); Senior Consultant, Glaucoma Department and Deputy Medical Director (Research) of the Singapore National Eye Centre (SNEC). He is also a full tenured Professor with the Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, and in 2018, he was conferred the Kwan Im Thong Hood Cho Temple Professorship of Ophthalmology, Duke-NUS Medical School, Singapore.

Professor Aung's research has secured more than S$20 million in competitive research grant funding. He has received numerous awards including the National Medical Research Council-Clinician Scientist Award (2005 and 2008), the President's Science Award (2009), the Nakajima (2007) and De Campo Awards (2013) from the Asia Pacific Academy of Ophthalmology, the Alcon Research Institute Award (2013), the Singapore Translational Research (STaR) Investigator Award (2014), the Robert Ritch Award for Excellence and Innovation in Glaucoma from the Glaucoma Foundation (2017), Eye and Vision Health Award 2018 -  Visionary Award and the Philippine Glaucoma Society - Manuel B. Agulto Award in 2018.

Professor Aung Tin currently has more than 570 publications, 15 book chapters and 14 patent applications under his name. He is on editorial boards of several journals including Ophthalmology, Progress in Retinal and Eye Research, Eye, Journal of Glaucoma and Graefe's Archive for Clinical and Experimental Ophthalmology. In addition to teaching, Professor Aung supervises and mentors young clinicians, fellows, researchers and students, especially in the areas of glaucoma and translational research. His achievements and professional standing led to his appointment in 2016-2017 as President of the World Glaucoma Association, where he currently serves as Immediate Past President and a member of the Board of Governors. He is Vice President of the Asian Angle Closure Glaucoma Club, is a member of the Executive Committee of the Asia Pacific Glaucoma Society, the Glaucoma Research Society, as well as a past President for the College of Ophthalmologists of Singapore.

Yeo Khung Keong.jpgDr Yeo Khung Keong
MBBS (S'pore), FACC, FAMS, FSCAI, ABIM (Internal Med, Cardiology & Interventional Cardiology, USA), ABVM (Vascular Medicine & Endovascular, USA)
Deputy Group Chief Medical Informatics Officer (Research), SingHealth
Senior Consultant National Heart Centre Singapore


Dr. Yeo graduated in 1997 from the National University of Singapore where he obtained his Bachelor of Medicine and Surgery. He subsequently trained in the United States of America and obtained his American Board of Internal Medicine Certifications in Internal Medicine, Cardiovascular Medicine and Interventional cardiology. Currently, Dr Yeo is a senior consultant cardiologist and interventional cardiologst in the department of cardiology and leads the MitraClip program at the National Heart Centre Singapore. He is also the Scientific Lead for the Clinical Sciences and Database Core at the National Heart Research Institute Singapore. He is also the Deputy Group Chief Medical Informatics Officer (Research) for SingHealth Health Systems. Dr Yeo previously served as the Program Director of the SingHealth Cardiology Senior Residency Program and is currently the Academic Vice Chair (Training and Education) for the SingHealth Duke-NUS Cardiovascular Academic Clinical Program. He is a member of the Singapore Cardiac Society, American Heart Association, and is a Fellow of the European Society of Cardiology (FESC), American College of Cardiology (FACC), the Asian Pacific Society of Cardiology (FAPSC), the Asian Pacific Society of Interventional Cardiology, and the Society of Cardiovascular Angiography and Interventions (FSCAI). He is the Chair of the Scientific Advisory Board for the Asian Pacific Society of Cardiology. He has published widely in international peer-reviewed journals and is a peer-reviewer for Circulation, the American Journal of Cardiology, Heart, Journal of the American College of Cardiology: Cardiovascular Intervention, Korean Circulation Journal, ASEAN Heart Journal and Singapore Medical Journal. He is a member of the Editorial Board of the Korea Circulation Journal and Asiaintervention. Dr Yeo is interested in long-term cardiovascular outcomes in Health Services Research and the use of data science to develop insights into the diagnosis and management of heart disease. He has published multiple papers comparing outcomes in large studies including those from large registries in the USA. Currently, he is the PI of the SingCLOUD registry, which is a national registry of all patients with coronary artery disease and heart failure. Dr Yeo is also the PI for SingHEART, which is a prospective observational study or normal volunteers in Singapore. SingHEART combines whole genome sequencing with deep phenotyping (cardiac MRI, CT calcium score, ambulatory BP and ECG, fitness tracker, and blood tests) and long-term clinical follow-up for 20 years.